New Technique Blocks The Pain Of Breast Surgery

October 21, 1997

SAN DIEGO -- Giving women regional pain relief rather than general anesthesia for breast surgery substantially relieves debilitating nausea and discomfort, according to physicians at Duke University Medical Center. Many of the women leave the hospital hours after their surgery, even though they have the choice of staying overnight or longer.

The procedure, called a paravertebral block, offers women up to 30 hours of pain relief and little associated nausea. By contrast, breast surgery using traditional general anesthesia has one of the highest rates of postoperative pain, nausea and vomiting compared to other types of surgery, according to Duke anesthesiologist Dr. Roy Greengrass.

General anesthesia does not block the transmission of pain reflexes to the brain and spinal cord, but with the block, "the central nervous system is unaware the body is being operated on," he said. "This technique reduces post-operative pain."

Greengrass compared the methods in 245 women and prepared the study findings for presentation Tuesday at the annual meeting of the American Society of Anesthesiologists. The women either had a mastectomy, lumpectomy or reconstructive surgery. He found that 98 percent of the patients who had surgery with general anesthesia required narcotics for pain relief after surgery, compared to 24 percent of women who received a paravertebral block. Many of the women that had a block required just an over-the-counter pain medication, Greengrass said.

The block reduced postoperative nausea and vomiting by more than 50 percent. Of the women who had general anesthesia, 39 percent required treatment for nausea and vomiting, compared to 19 percent of women who had a block, Greengrass reported.

The block consists of a series of injections to numb nerves that emerge from the spinal cord to supply the chest area without affecting overall lung or heart functioning. Because blood flow is low in those areas, the anesthetic is absorbed slowly and lasts a longtime. It is an old, seldomly-used technique that had been reserved for anesthetizing patients who needed chest operations, but who are too ill to risk general anesthesia. Greengrass adapted the block for breast surgery use after surgeons asked for a way to prevent the intense side effects caused by general anesthesia and narcotic-pain control.

Women are given local pain relief on their back before block injections are inserted, and they also receive an intravenous cocktail of sedatives and a drug to induce memory loss during the operation.

"It isn't the surgery itself that makes the women sick and requires hospitalization, but the effects of both the general anesthetic, which wears off quickly, and the narcotics that are then needed to control pain," said Greengrass. "The paravertebral block can offer women time to recover. The body has already begun to heal by the time the anesthetic wears off."

Greengrass says that one of the best results of the block is that it offers some comfort to women who already have to deal with the fact that they have been diagnosed with cancer.

At Duke now, more than 80 percent of women undergoing breast surgery choose the new technique. Of these, about one-third choose to go home within hours of their operation.

Letting patients decide what is best for them is what is important, Greengrass said. "We didn't develop the block to reduce hospital stays but to improve treatment. All we want to do is offer women a choice, both in their use of anesthesia and in whether or not they want to stay in the hospital."

The Duke technique is now being practiced at other medical centers, including the Mayo Clinic and Georgetown University Medical Center. "Although few medical centers are currently using regional anesthesia for major breast cancer operations, the technique offers a viable and effective alternative that may eventually be more widely available," Greengrass said.

Duke University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to